Keyword: EuroAPI

News

2024 Guidance Suspended: API Production Paused in Brindisi, Italy

19.03.2024 -

EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.

News

EuroAPI Collaborates with Contract Research Organization SpiroChem

26.01.2024 -

Active pharmaceutical ingredients manufacturer EuroAPI has started a collaboration with Basel, Switzerland-headquartered SpiroChem, a contract research organization (CRO)...

News

EuroAPI Appoints Ludwig de Mot as Chief Transformation Officer

08.01.2024 -

EuroAPI has appointed Ludwig de Mot as chief transformation officer and executive vice president (EVP).

News

EuroAPI Completes Acquisition of BianoGMP

22.11.2023 -

EuroAPI has completed the acquisition of BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides.

News

EuroAPI Announces New Governance

26.10.2023 -

EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane...

News

EuroAPI to Acquire German CDMO BianoGMP

29.08.2023 -

Active pharmaceutical ingredients manufacturer EuroAPI has agreed to acquire BianoGMP, a contract development and manufacturing organization (CDMO) specializing in...

News

EUROAPI to Invest €50 Million at Budapest

09.06.2023 -

Active Pharmaceutical Ingredient maker EuroAPI said it plans to invest €50 million in a new state-of-the-art production plant at its fully integrated Budapest site.

News

EuroAPI Invests €40 Million in French B12 Production

12.01.2023 -

Leading active pharmaceutical ingredients manufacturer EuroAPI plans to invest €40 million at its site in Saint-Aubin-lès-Elbeuf, France, to launch a new production...